Hai Qing Hua
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Currently, Hai Qing Hua is Executive Director at Duality Biotherapeutics, Inc. since 2026.
Formerly, Dr. Hua was Head-Biopharmaceuticals at Hansoh Pharmaceutical Group Co., Ltd. Education includes a doctorate from the University of Zurich in 2009, an undergraduate degree from Tsinghua University in 2003, and a doctorate from Columbia University Irving Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 23/03/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansoh Pharmaceutical Group Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells & develops pharmaceutical products | Health Technology |
Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.